Xiaomin Chen
Fortuna: 3 M $ al 31/08/2026
Fortuna: 3 M $ al 31/08/2026
Xiaomin Chen is currently the Chairman & Chief Executive Officer at Advanced Biomed, Inc. since 2026.
Dr. Chen is also the Chief Executive Officer at Acellent Technologies (Hong Kong) Co., Ltd. since 2019.
Dr. Chen earned a doctorate degree from Rutgers State University of New Jersey in 2006 and an undergraduate degree from Shanghai Jiao Tong University in 1998.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADVANCED BIOMED, INC. 16,34 % | 29/05/2026 | 270.000 ( 16,34 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADVANCED BIOMED INC. | Director Ejecutivo | 28/04/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Jiao Tong University
Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Biomed, Inc.
Advanced Biomed, Inc. BiotechnologyHealth Technology Operates as a holding company whose subsidiaries engages in research and development & production of microfluidic biochip technologies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.